Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
292 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-05-19)
Due Date
May 19, 2026
Grace Period Ends
November 19, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 19, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 22, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| May 19, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 14, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 11, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 7, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 31, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 31, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 27, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 26, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 26, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 23, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 23, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 20, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 18, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 18, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 18, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 16, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 12, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 12, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 12, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 31, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 29, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 29, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 29, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 20, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 18, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 18, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 18, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 18, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 21, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 21, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 1, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 16, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 16, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 16, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 16, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 16, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 13, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 23, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 24, 2016 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 23, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 22, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
First Use Anywhere:
Mar 26, 2020
First Use in Commerce:
Mar 26, 2020
Additional Information
Design Mark
The mark consists of a hexagon, bisected be a swoosh, followed by the text and numeral "EXONDYS 51" over the text "(eteplirsen) Injection"; the color gray is intended to show shading or contrast only.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
EXONDYS FIFTY ONE ETEPLIRSEN INJECTION
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"51 ETEPLIRSEN INJECTION"